Event is Co-Sponsored by Intuitive Surgical and ATS Medical
MINNEAPOLIS, April 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first Frontiers in Cryoablation Symposium to be held at the American Association for Thoracic Surgery Annual Meeting in San Diego. The symposium is the first in a series of meetings intended to further the evolution and direction for cryoablation therapy, a treatment for atrial fibrillation. Dr. James L. Cox, inventor of the Maze procedure and Medical Director for ATS Medical, will lead the symposia series. The program will include a preeminent faculty of cardiac surgeons reporting on current techniques, robotics, and the future of minimally invasive cryoablation utilizing the ATS CryoMaze(TM) Surgical Ablation System.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)
This first symposium, titled "Current Techniques, Robotics and the
Future of Minimally Invasive Cryoablation" is sponsored collaboratively by
ATS Medical and Intuitive Surgical, the makers of the da Vinci(R) Surgical
System (Nasdaq: ISRG). The symposium follows the recent market release of
Intuitive Surgical's Endowrist Cardiac Probe Grasper -- a device
specifically designed to assist the da Vinci System in manipulating ATS
CryoMaze Surgical Ablation Probes to complete the Cox Maze III procedure
'/>"/>
| SOURCE ATS Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |